Fredun Pharmaceuticals Ltd

Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.

Intimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India

Company Update / General View filing →

Monitoring Agency Report

Monitoring Agency Report dated 14.08.2026

Company Update / Monitoring Agency Report View filing →

539730 - Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026

Statement of Deviation or Variation For the Quarter Ended June 30, 2026.

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

Analyst / Investor Meet - Outcome

Audio Recording Q1 FY27 'Earnings Conference Call' of Fredun Pharmaceuticals Limited.

Company Update / Analyst / Investor Meet View filing →

Newspaper Publication

Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026

Company Update / Newspaper Publication View filing →

Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday, 05Th August, 2026.

Fredun Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Notice is hereby given ....

Board Meeting / Board Meeting View filing →

Allotment

Allotment of Bonus Equity Shares.

Company Update / Allotment of Equity Shares View filing →

Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Issue Of Bonus Equity Shares.

Intimation of Record Date pursuant to SEBI LODR Regulations, 2015 for Issue of Bonus Equity Shares.

Corp. Action / Record Date View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of 39th Annual General Meeting

AGM/EGM / AGM View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Scrutinizer's Report for 39th Annual General Meeting.

AGM/EGM / AGM View filing →

Closure of Trading Window

Intimation of Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →

Analyst / Investor Meet - Outcome

Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call'

Company Update / Analyst / Investor Meet View filing →

Newspaper Publication

Newspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June, 2026 through video conference/other audio visual means.

Company Update / Newspaper Publication View filing →

Analyst / Investor Meet - Intimation

Revised intimation of Earnings Conference Call for the quarter Q4 of FY26.

Company Update / Analyst / Investor Meet View filing →

Reg. 34 (1) Annual Report.

Annual Report of Fredun Pharmaceuticals Limited for the Financial Year 2025-2026 including the Notice of the 39th Annual General Meeting of the Company scheduled to be held on Tuesday, ....

Others / Reg. 34 (1) Annual Report View filing →

Notice Convening 39Th Annual General Meeting ('AGM') Of Fredun Pharmaceuticals Limited

Notice convening 39th Annual General Meeting ("AGM") of Fredun Pharmaceuticals Limited

AGM/EGM / AGM View filing →

Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM).

Notice of Book Closure for the purpose of 39th Annual General Meeting (AGM)

Corp. Action / Book Closure View filing →

Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26

Intimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26

Corp. Action / Record Date View filing →

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")

Company Update / General View filing →